SNP Genotypes of Olfactory Receptor Genes Associated with Olfactory Ability in German Shepherd Dogs

Total Page:16

File Type:pdf, Size:1020Kb

SNP Genotypes of Olfactory Receptor Genes Associated with Olfactory Ability in German Shepherd Dogs SHORT COMMUNICATION doi: 10.1111/age.12389 SNP genotypes of olfactory receptor genes associated with olfactory ability in German Shepherd dogs † ‡ – M. Yang*, G.-J. Geng , W. Zhang , L. Cui§, H.-X. Zhang and J.-L. Zheng‡ † *Police-dog Technology Department, National Police University of China, Shenyang, Liaoning 110034, China. Technology Department, ‡ Shenyang Traffic Police Detachment, Shenyang, Liaoning 110001, China. Forensic Medicine Department, National Police University of China, Shenyang, Liaoning 110854, China. §Document Inspection Department, National Police University of China, Shenyang, Liaoning – 110854, China. Mark Inspection Department, National Police University of China, Shenyang, Liaoning 110854, China. Summary To find out the relationship between SNP genotypes of canine olfactory receptor genes and olfactory ability, 28 males and 20 females from German Shepherd dogs in police service were scored by odor detection tests and analyzed using the Beckman GenomeLab SNPstream. The representative 22 SNP loci from the exonic regions of 12 olfactory receptor genes were investigated, and three kinds of odor (human, ice drug and trinitrotoluene) were detected. The results showed that the SNP genotypes at the OR10H1-like:c.632C>T, OR10H1-like:c.770A>T, OR2K2-like:c.518G>A, OR4C11-like: c.511T>G and OR4C11-like:c.692G>A loci had a statistically significant effect on the scenting abilities (P < 0.001). The kind of odor influenced the performances of the dogs (P < 0.001). In addition, there were interactions between genotype and the kind of odor at the following loci: OR10H1-like:c.632C>T, OR10H1-like:c.770A>T, OR4C11-like:c.511T>G and OR4C11-like:c.692G>A(P< 0.001). The dogs with genotype CC at the OR10H1-like: c.632C>T, genotype AA at the OR10H1-like:c.770A>T, genotype TT at the OR4C11-like: c.511T>G and genotype GG at the OR4C11-like:c.692G>A loci did better at detecting the ice drug. We concluded that there was linkage between certain SNP genotypes and the olfactory ability of dogs and that SNP genotypes might be useful in determining dogs’ scenting potential. Keywords correlation, dog, scenting behavior, genetic markers Certain dog breeds, such as German Shepherd dogs, are Chen et al. 2012; Randi et al. 2014). Gene polymorphisms very popular in the field of police work because of their are associated with behavior of dogs in the fields of social sensitive nose. Because of the willingness of these dogs to behavior, scenting behavior, activity–impulsivity, etc. cooperate with humans, police forces make use of this trait (Hejjas et al. 2007; Kubinyi et al. 2012; Kis et al. 2014). in dogs as tools for detecting a variety of odors such as Over half of the canine olfactory receptor (cOR) genes explosives, drugs, humans and even molds (Lesniak et al. were found to show high polymorphism, some of which 2008; Pinc et al. 2011; Lippi and Cervellin 2012). Whether were breed specific and some of which might affect the olfactory sensation of dogs is acute or not is often individual olfactory perception (Keller and Vosshall 2008; evaluated through the use of many kinds of behavior tests, Robin et al. 2009; Quignon et al. 2012; Kim et al. 2012). which have raised questions about the objectivity the tests Therefore, the correlation between the genetic polymor- in the absence of a ‘gold standard’ (Doty and Kamath phism of cOR genes and olfactory ability was further 2014). The spread of different phenotypes in dogs has studied. If a certain allele is likely to endow olfactory resulted from restricting gene flow and artificially selecting receptors with ligand-binding capacity, that might con- offspring (Spady and Ostrander 2008; Akey et al. 2010; tribute to the olfaction sensitivity of dogs. Lesniak et al. (2008) verified that the specific alleles at two loci, cOR9S13: Address for correspondence c.592G>A and cOR52N9:c.176A>G, were statistically sig- nificantly linked to odor recognition capabilities of dogs. M. Yang, Police-dog Technology Department, National Police University of China, 4 Baishan Road, Yuhong District, Shenyang, However, it is possible that a certain polymorphism at a Liaoning 110034, China. given locus does not fully determine a dog’s odor sensing E-mail: [email protected] skills. Understanding the genetic mechanism of olfactory Accepted for publication 13 October 2015 behavior traits could help breeders to breed dogs that cater 240 © 2015 Stichting International Foundation for Animal Genetics, 47, 240–244 OR genotype associated with olfactory ability 241 to human requirements and create a genetic method of Yij ¼ l þ Gi þ Oj þ (GO)ij þ eij; picking out excellent individuals. l An experimental group of 48 German Shepherd dogs where Yij is the score of the smelling ability, is the total (males, n = 28; females, n = 20), 2–3 years old, were mean values, Gi is the major effect on genotype i level, Ej is selected from the Police Dog Technology School of Ministry the major effect on odor j level, (GO)ij is the interaction of Ɛ of Public Security, China. All the dogs had reached the genotype with the kind of odor on smelling ability and ij is standard for police dogs and were treated in a humane the effect of random error. manner (Lesniak et al. 2008). Experienced handlers Overall, each SNP locus had one main effective allele recorded the sniffing ability of each dog, which had been (Table S5) with a frequency between 0.594 and 0.917. In > trained to detect specific kinds of odor, including the odors particular, the OR2K2-like:c.72 C/T, cOR52E17: > > > of human, ice drug and trinitrotoluene, and were in the last c.791G A, OR2M5:c.98T C, OR2M5:c.170C T, OR2M5: > > phase of training. The standards for scoring are shown in c.862G A and OR08H10:c.241G A loci presented as Table S1. homozygous, reflecting a unique genotype because some A blood sample was obtained from each dog, and then alleles are breed specific or rare in the dog population, DNA was isolated. Twenty-two representative SNP sites, of whereas the other loci presented two or three genotypes which five were breed specific in German Shepherd dogs, lay (Robin et al. 2009; Kim et al. 2012). According to the allele in exonic regions of 12 cOR genes (Robin et al. 2009) frequencies, genetic disequilibrium was found at the > > (Table S2). Pairs of specific primers for 12 cOR gene fraction OR52J3:c.469G A, OR2K2-like:c.518G A and OR4C11- > v2 > < amplification and 22 single extensive primers for SNP like:c.256A G loci ( 9.210, P 0.01). On the contrary, the 13 other loci were in Hardy–Weinberg equilibrium genotypes were designed using the PRIMER-BLAST and PRIMER (v2 < 5.991, P > 0.05). Meanwhile, 16 loci showed low PREMIER 5 programs. The primer sequences, fragment sizes < and annealing temperatures (Tm) mentioned above are polymorphism levels (PIC 0.25), and six loci showed a < < shown in Tables S3 and S4. medium level of polymorphism (0.25 PIC 0.50) Polymerase chain reaction (PCR) was conducted using a (Table 1). This phenomenon might be a result of the Veriti thermal cycler (Applied Biosystems, Inc.) in a total recruitment system used for police dogs. volume of 50 ll that included 4 ll of 100 ng of genomic We also observed that the olfactory sensitivity of dogs varied with certain genotypes. The biggest difference DNA, 25 ll of Premix Taq, 1 lM (final concentration) of > each specific primer and up to 50 ll of water. The following occurred relating to the OR4C11-like:c.511T G and > conditions for the reaction were applied: 10 s at 98 °C, 30 s OR4C11-like:c.692G A loci, as dogs with a TT and GG at 53 °Cor58°C, 30 s at 72 °C and 32 amplification genotype respectively were scored at 26.85 for the detection cycles. PCR products were loaded onto a 2% agarose gel stained with GeneFinder (Biov), and DNA was extracted from the gel. SNP–primer extension reaction was performed Table 1 Genetic polymorphism analysis of SNPs. in a 5-ll reaction system that consisted 2 ll of Premix, 2 ll 2 Num Loci v He PIC of the purified PCR products and 1 ll(1lM) of primer, starting with 25 cycles of denaturation at 96 °C for 10 s, 1 OR10H1-like:c.632C>T 0.087 0.202 0.183 OR10H1-like: > annealing at 50 °C for 10 s and extension at 72 °C for 30 s, 2 c.770A T 0.087 0.202 0.183 3 OR52J3:c.469G>A 42.013 0.278 0.239 followed by an extra extension at 72 °C for 5 min. A total 4 OR2K2-like:c.172>C/T – 00 of 4.25 ll of product digestion was initiated by adding 5 OR2K2-like:c.518G>A 41.245 0.249 0.217 0.5 llof109 buffer and 0.25 llof1U/ll SAP (TaKaRa) 6 OR8S1:c.658T>C 1.732 0.329 0.275 for 1 h in a 37 °C water bath and for 15 min in a 80 °C 7 OR1L4:c.214G>C 0.167 0.457 0.353 OR51I2-like: > water bath. One half microliter (0.5 ll) of the product was 8 c.710T G 0.034 0.186 0.169 9 OR51I2-like:c.770T>C 0.034 0.186 0.169 added to 0.5 ll of Size Standard 80 and 39 ll of sample 10 OR51I2-like:c.778T>A 0.034 0.186 0.169 loading solution. The capillary electrophoresis was ana- 11 OR49-like:c.147A>G 0.088 0.152 0.141 lyzed on a Beckman GeXP Genetic Analysis System 12 cOR52E17:c.214G>A 1.732 0.329 0.275 according to GenomeLab SNP-Start Primer Extension Kit 13 cOR52E17:c.791G>A – 00 OR2M5: > – (Beckman).
Recommended publications
  • Genetic Variation Across the Human Olfactory Receptor Repertoire Alters Odor Perception
    bioRxiv preprint doi: https://doi.org/10.1101/212431; this version posted November 1, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Genetic variation across the human olfactory receptor repertoire alters odor perception Casey Trimmer1,*, Andreas Keller2, Nicolle R. Murphy1, Lindsey L. Snyder1, Jason R. Willer3, Maira Nagai4,5, Nicholas Katsanis3, Leslie B. Vosshall2,6,7, Hiroaki Matsunami4,8, and Joel D. Mainland1,9 1Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA 2Laboratory of Neurogenetics and Behavior, The Rockefeller University, New York, New York, USA 3Center for Human Disease Modeling, Duke University Medical Center, Durham, North Carolina, USA 4Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA 5Department of Biochemistry, University of Sao Paulo, Sao Paulo, Brazil 6Howard Hughes Medical Institute, New York, New York, USA 7Kavli Neural Systems Institute, New York, New York, USA 8Department of Neurobiology and Duke Institute for Brain Sciences, Duke University Medical Center, Durham, North Carolina, USA 9Department of Neuroscience, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA *[email protected] ABSTRACT The human olfactory receptor repertoire is characterized by an abundance of genetic variation that affects receptor response, but the perceptual effects of this variation are unclear. To address this issue, we sequenced the OR repertoire in 332 individuals and examined the relationship between genetic variation and 276 olfactory phenotypes, including the perceived intensity and pleasantness of 68 odorants at two concentrations, detection thresholds of three odorants, and general olfactory acuity.
    [Show full text]
  • Supplementary Figure S4
    18DCIS 18IDC Supplementary FigureS4 22DCIS 22IDC C D B A E (0.77) (0.78) 16DCIS 14DCIS 28DCIS 16IDC 28IDC (0.43) (0.49) 0 ADAMTS12 (p.E1469K) 14IDC ERBB2, LASP1,CDK12( CCNE1 ( NUTM2B SDHC,FCGR2B,PBX1,TPR( CD1D, B4GALT3, BCL9, FLG,NUP21OL,TPM3,TDRD10,RIT1,LMNA,PRCC,NTRK1 0 ADAMTS16 (p.E67K) (0.67) (0.89) (0.54) 0 ARHGEF38 (p.P179Hfs*29) 0 ATG9B (p.P823S) (0.68) (1.0) ARID5B, CCDC6 CCNE1, TSHZ3,CEP89 CREB3L2,TRIM24 BRAF, EGFR (7p11); 0 ABRACL (p.R35H) 0 CATSPER1 (p.P152H) 0 ADAMTS18 (p.Y799C) 19q12 0 CCDC88C (p.X1371_splice) (0) 0 ADRA1A (p.P327L) (10q22.3) 0 CCNF (p.D637N) −4 −2 −4 −2 0 AKAP4 (p.G454A) 0 CDYL (p.Y353Lfs*5) −4 −2 Log2 Ratio Log2 Ratio −4 −2 Log2 Ratio Log2 Ratio 0 2 4 0 2 4 0 ARID2 (p.R1068H) 0 COL27A1 (p.G646E) 0 2 4 0 2 4 2 EDRF1 (p.E521K) 0 ARPP21 (p.P791L) ) 0 DDX11 (p.E78K) 2 GPR101, p.A174V 0 ARPP21 (p.P791T) 0 DMGDH (p.W606C) 5 ANP32B, p.G237S 16IDC (Ploidy:2.01) 16DCIS (Ploidy:2.02) 14IDC (Ploidy:2.01) 14DCIS (Ploidy:2.9) -3 -2 -1 -3 -2 -1 -3 -2 -1 -3 -2 -1 -3 -2 -1 -3 -2 -1 Log Ratio Log Ratio Log Ratio Log Ratio 12DCIS 0 ASPM (p.S222T) Log Ratio Log Ratio 0 FMN2 (p.G941A) 20 1 2 3 2 0 1 2 3 2 ERBB3 (p.D297Y) 2 0 1 2 3 20 1 2 3 0 ATRX (p.L1276I) 20 1 2 3 2 0 1 2 3 0 GALNT18 (p.F92L) 2 MAPK4, p.H147Y 0 GALNTL6 (p.E236K) 5 C11orf1, p.Y53C (10q21.2); 0 ATRX (p.R1401W) PIK3CA, p.H1047R 28IDC (Ploidy:2.0) 28DCIS (Ploidy:2.0) 22IDC (Ploidy:3.7) 22DCIS (Ploidy:4.1) 18IDC (Ploidy:3.9) 18DCIS (Ploidy:2.3) 17q12 0 HCFC1 (p.S2025C) 2 LCMT1 (p.S34A) 0 ATXN7L2 (p.X453_splice) SPEN, p.P677Lfs*13 CBFB 1 2 3 4 5 6 7 8 9 10 11
    [Show full text]
  • Sean Raspet – Molecules
    1. Commercial name: Fructaplex© IUPAC Name: 2-(3,3-dimethylcyclohexyl)-2,5,5-trimethyl-1,3-dioxane SMILES: CC1(C)CCCC(C1)C2(C)OCC(C)(C)CO2 Molecular weight: 240.39 g/mol Volume (cubic Angstroems): 258.88 Atoms number (non-hydrogen): 17 miLogP: 4.43 Structure: Biological Properties: Predicted Druglikenessi: GPCR ligand -0.23 Ion channel modulator -0.03 Kinase inhibitor -0.6 Nuclear receptor ligand 0.15 Protease inhibitor -0.28 Enzyme inhibitor 0.15 Commercial name: Fructaplex© IUPAC Name: 2-(3,3-dimethylcyclohexyl)-2,5,5-trimethyl-1,3-dioxane SMILES: CC1(C)CCCC(C1)C2(C)OCC(C)(C)CO2 Predicted Olfactory Receptor Activityii: OR2L13 83.715% OR1G1 82.761% OR10J5 80.569% OR2W1 78.180% OR7A2 77.696% 2. Commercial name: Sylvoxime© IUPAC Name: N-[4-(1-ethoxyethenyl)-3,3,5,5tetramethylcyclohexylidene]hydroxylamine SMILES: CCOC(=C)C1C(C)(C)CC(CC1(C)C)=NO Molecular weight: 239.36 Volume (cubic Angstroems): 252.83 Atoms number (non-hydrogen): 17 miLogP: 4.33 Structure: Biological Properties: Predicted Druglikeness: GPCR ligand -0.6 Ion channel modulator -0.41 Kinase inhibitor -0.93 Nuclear receptor ligand -0.17 Protease inhibitor -0.39 Enzyme inhibitor 0.01 Commercial name: Sylvoxime© IUPAC Name: N-[4-(1-ethoxyethenyl)-3,3,5,5tetramethylcyclohexylidene]hydroxylamine SMILES: CCOC(=C)C1C(C)(C)CC(CC1(C)C)=NO Predicted Olfactory Receptor Activity: OR52D1 71.900% OR1G1 70.394% 0R52I2 70.392% OR52I1 70.390% OR2Y1 70.378% 3. Commercial name: Hyperflor© IUPAC Name: 2-benzyl-1,3-dioxan-5-one SMILES: O=C1COC(CC2=CC=CC=C2)OC1 Molecular weight: 192.21 g/mol Volume
    [Show full text]
  • Chromophobe Renal Cell Carcinoma with and Without Sarcomatoid Change: a Clinicopathological, Comparative Genomic Hybridization, and Whole-Exome Sequencing Study
    Am J Transl Res 2015;7(11):2482-2499 www.ajtr.org /ISSN:1943-8141/AJTR0014993 Original Article Chromophobe renal cell carcinoma with and without sarcomatoid change: a clinicopathological, comparative genomic hybridization, and whole-exome sequencing study Yuan Ren1*, Kunpeng Liu1*, Xueling Kang3, Lijuan Pang1, Yan Qi1, Zhenyan Hu1, Wei Jia1, Haijun Zhang1, Li Li1, Jianming Hu1, Weihua Liang1, Jin Zhao1, Hong Zou1*, Xianglin Yuan2, Feng Li1* 1Department of Pathology, School of Medicine, First Affiliated Hospital, Shihezi University, Key Laboratory of Xinjiang Endemic and Ethnic Diseases, Ministry of Education of China, Shihezi, China; 2Tongji Hospital Cancer Center, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; 3Department of Pathology, Shanghai General Hospital, Shanghai, China. *Equal contributors. Received August 24, 2015; Accepted October 13, 2015; Epub November 15, 2015; Published November 30, 2015 Abstract: Chromophobe renal cell carcinomas (CRCC) with and without sarcomatoid change have different out- comes; however, fewstudies have compared their genetic profiles. Therefore, we identified the genomic alteration- sin CRCC common type (CRCC C) (n=8) and CRCC with sarcomatoid change (CRCC S) (n=4) using comparative genomic hybridization (CGH) and whole-exome sequencing. The CGH profiles showed that the CRCC C group had more chromosomal losses (72 vs. 18) but fewer chromosomal gains (23 vs. 57) than the CRCC S group. Losses of chromosomes 1p, 8p21-23, 10p16-20, 10p12-ter, 13p20-30, and 17p13 and gains of chromosomes 1q11, 1q21-23, 1p13-15, 2p23-24, and 3p21-ter differed between the groups. Whole-exome sequencing showed that the mutational status of 270 genes differed between CRCC (n=12) and normal renal tissues (n=18).
    [Show full text]
  • A Novel Chromosome 19P13.12 Deletion in a Child with Multiple Congenital Anomalies Daniel R
    RESEARCH ARTICLE A Novel Chromosome 19p13.12 Deletion in a Child With Multiple Congenital Anomalies Daniel R. Jensen,1 Donna M. Martin,2,3 Stephen Gebarski,4 Trilochan Sahoo,5 Ellen K. Brundage,5 A. Craig Chinault,5 Edgar A. Otto,2 Moumita Chaki,2 Friedhelm Hildebrandt,2,3,6 Sau Wai Cheung,5 and Marci M. Lesperance1* 1Division of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, University of Michigan Health System, Ann Arbor, Michigan 2Department of Pediatrics and Communicable Diseases, University of Michigan Health System, Ann Arbor, Michigan 3Department of Human Genetics, University of Michigan Health System, Ann Arbor, Michigan 4Division of Neuroradiology, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan 5Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 6Howard Hughes Medical Institute, University of Michigan Health System, Ann Arbor, Michigan Received 17 March 2008; Accepted 21 November 2008 We describe a patient with multiple congenital anomalies in- cluding deafness, lacrimal duct stenosis, strabismus, bilateral How to Cite this Article: cervical sinuses, congenital cardiac defects, hypoplasia of the Jensen DR, Martin DM, Gebarski S, Sahoo T, corpus callosum, and hypoplasia of the cerebellar vermis. Muta- Brundage EK, Chinault AC, Otto EA, Chaki M, tion analysis of EYA1, SIX1, and SIX5, genes that underlie Hildebrandt F, Cheung SW, Lesperance MM. otofaciocervical and/or branchio-oto-renal syndrome, was neg- 2009. A novel chromosome 19p13.12 deletion ative. Pathologic diagnosis of the excised cervical sinus tracts was in a child with multiple congenital anomalies. revised on re-examination to heterotopic salivary gland tissue.
    [Show full text]
  • Genome-Wide Profiling of Druggable Active Tumor Defense Mechanisms to Enhance Cancer Immunotherapy
    bioRxiv preprint doi: https://doi.org/10.1101/843185; this version posted November 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Genome-wide profiling of druggable active tumor defense mechanisms to enhance cancer immunotherapy Rigel J. Kishton1,2,*,#, Shashank J. Patel1,2,†,*, Suman K. Vodnala1,2, Amy E. Decker3, Yogin Patel1,2, Madhusudhanan Sukumar1,2, Tori N. Yamamoto1,2,4, Zhiya Yu1,2, Michelle Ji1,2, Amanda N. Henning1,2, Devikala Gurusamy1,2, Douglas C. Palmer1,2, Winifred Lo1, Anna Pasetto1, Parisa Malekzadeh1, Drew C. Deniger1, Kris C. Wood3, Neville E. Sanjana5,6, Nicholas P. Restifo1,2, #, § 1Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA 2Center for Cell-Based Therapy, National Cancer Institute, Bethesda, MD 20892, USA 3Department of Pharmacology & Cancer Biology, Duke University School of Medicine, Durham, NC, USA 4Immunology Graduate Group, University of Pennsylvania, Philadelphia, PA 19104, USA 5New York Genome Center, New York, NY 10013 USA 6Department of Biology, New York University, New York, NY 10003, USA *These authors contributed equally to this work. †Present address: NextCure Inc., Beltsville, MD 20705, USA §Present address: Lyell Immunopharma, South San Francisco, CA 94080, USA #Corresponding authors. NPR: [email protected]. RJK: [email protected]. bioRxiv preprint doi: https://doi.org/10.1101/843185; this version posted November 15, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission.
    [Show full text]
  • Clinical, Molecular, and Immune Analysis of Dabrafenib-Trametinib
    Supplementary Online Content Chen G, McQuade JL, Panka DJ, et al. Clinical, molecular and immune analysis of dabrafenib-trametinib combination treatment for metastatic melanoma that progressed during BRAF inhibitor monotherapy: a phase 2 clinical trial. JAMA Oncology. Published online April 28, 2016. doi:10.1001/jamaoncol.2016.0509. eMethods. eReferences. eTable 1. Clinical efficacy eTable 2. Adverse events eTable 3. Correlation of baseline patient characteristics with treatment outcomes eTable 4. Patient responses and baseline IHC results eFigure 1. Kaplan-Meier analysis of overall survival eFigure 2. Correlation between IHC and RNAseq results eFigure 3. pPRAS40 expression and PFS eFigure 4. Baseline and treatment-induced changes in immune infiltrates eFigure 5. PD-L1 expression eTable 5. Nonsynonymous mutations detected by WES in baseline tumors This supplementary material has been provided by the authors to give readers additional information about their work. © 2016 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 09/30/2021 eMethods Whole exome sequencing Whole exome capture libraries for both tumor and normal samples were constructed using 100ng genomic DNA input and following the protocol as described by Fisher et al.,3 with the following adapter modification: Illumina paired end adapters were replaced with palindromic forked adapters with unique 8 base index sequences embedded within the adapter. In-solution hybrid selection was performed using the Illumina Rapid Capture Exome enrichment kit with 38Mb target territory (29Mb baited). The targeted region includes 98.3% of the intervals in the Refseq exome database. Dual-indexed libraries were pooled into groups of up to 96 samples prior to hybridization.
    [Show full text]
  • Positive Selection, Relaxation, and Acceleration in the Evolution of the Human and Chimp Genome
    Positive Selection, Relaxation, and Acceleration in the Evolution of the Human and Chimp Genome Leonardo Arbiza1, Joaquı´n Dopazo2, Herna´n Dopazo1* 1 Pharmacogenomics and Comparative Genomics Unit, Centro de Investigacio´nPrı´ncipe Felipe (CIPF), Valencia, Spain, 2 Functional Genomics Unit, Bioinformatics Department, Centro de Investigacio´nPrı´ncipe Felipe (CIPF), Valencia, Spain For years evolutionary biologists have been interested in searching for the genetic bases underlying humanness. Recent efforts at a large or a complete genomic scale have been conducted to search for positively selected genes in human and in chimp. However, recently developed methods allowing for a more sensitive and controlled approach in the detection of positive selection can be employed. Here, using 13,198 genes, we have deduced the sets of genes involved in rate acceleration, positive selection, and relaxation of selective constraints in human, in chimp, and in their ancestral lineage since the divergence from murids. Significant deviations from the strict molecular clock were observed in 469 human and in 651 chimp genes. The more stringent branch-site test of positive selection detected 108 human and 577 chimp positively selected genes. An important proportion of the positively selected genes did not show a significant acceleration in rates, and similarly, many of the accelerated genes did not show significant signals of positive selection. Functional differentiation of genes under rate acceleration, positive selection, and relaxation was not statistically significant between human and chimp with the exception of terms related to G-protein coupled receptors and sensory perception. Both of these were over-represented under relaxation in human in relation to chimp.
    [Show full text]
  • The Mouse Solitary Odorant Receptor Gene Promoters As Models for the Study of Odorant Receptor Gene Choice
    RESEARCH ARTICLE The Mouse Solitary Odorant Receptor Gene Promoters as Models for the Study of Odorant Receptor Gene Choice Andrea Degl'Innocenti1,2*, Marta Parrilla1☯, Bettina Harr3☯, Meike Teschke3☯ 1 Max-Planck-Institut für Biophysik, Frankfurt am Main, Germany, 2 Unità di Biologia Cellulare e dello Sviluppo, Dipartimento di Biologia, Università di Pisa, Pisa, Italy, 3 Abteilung Evolutionsgenetik, Max-Planck- Institut für Evolutionsbiologie, Plön, Germany ☯ These authors contributed equally to this work. * [email protected] Abstract OPEN ACCESS Citation: Degl'Innocenti A, Parrilla M, Harr B, Background Teschke M (2016) The Mouse Solitary Odorant In vertebrates, several anatomical regions located within the nasal cavity mediate olfaction. Receptor Gene Promoters as Models for the Study of Odorant Receptor Gene Choice. PLoS ONE 11(1): Among these, the main olfactory epithelium detects most conventional odorants. Olfactory e0144698. doi:10.1371/journal.pone.0144698 sensory neurons, provided with cilia exposed to the air, detect volatile chemicals via an Editor: Johannes Reisert, Monell Chemical Senses extremely large family of seven-transmembrane chemoreceptors named odorant receptors. Center, UNITED STATES Their genes are expressed in a monogenic and monoallelic fashion: a single allele of a sin- Received: June 26, 2015 gle odorant receptor gene is transcribed in a given mature neuron, through a still uncharac- terized molecular mechanism known as odorant receptor gene choice. Accepted: November 23, 2015 Published: January 21, 2016 Copyright: © 2016 Degl'Innocenti et al. This is an Aim open access article distributed under the terms of the Odorant receptor genes are typically arranged in genomic clusters, but a few are isolated Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any (we call them solitary) from the others within a region broader than 1 Mb upstream and medium, provided the original author and source are downstream with respect to their transcript's coordinates.
    [Show full text]
  • The Hypothalamus As a Hub for SARS-Cov-2 Brain Infection and Pathogenesis
    bioRxiv preprint doi: https://doi.org/10.1101/2020.06.08.139329; this version posted June 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. The hypothalamus as a hub for SARS-CoV-2 brain infection and pathogenesis Sreekala Nampoothiri1,2#, Florent Sauve1,2#, Gaëtan Ternier1,2ƒ, Daniela Fernandois1,2 ƒ, Caio Coelho1,2, Monica ImBernon1,2, Eleonora Deligia1,2, Romain PerBet1, Vincent Florent1,2,3, Marc Baroncini1,2, Florence Pasquier1,4, François Trottein5, Claude-Alain Maurage1,2, Virginie Mattot1,2‡, Paolo GiacoBini1,2‡, S. Rasika1,2‡*, Vincent Prevot1,2‡* 1 Univ. Lille, Inserm, CHU Lille, Lille Neuroscience & Cognition, DistAlz, UMR-S 1172, Lille, France 2 LaBoratorY of Development and PlasticitY of the Neuroendocrine Brain, FHU 1000 daYs for health, EGID, School of Medicine, Lille, France 3 Nutrition, Arras General Hospital, Arras, France 4 Centre mémoire ressources et recherche, CHU Lille, LiCEND, Lille, France 5 Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and ImmunitY of Lille (CIIL), Lille, France. # and ƒ These authors contriButed equallY to this work. ‡ These authors directed this work *Correspondence to: [email protected] and [email protected] Short title: Covid-19: the hypothalamic hypothesis 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.06.08.139329; this version posted June 19, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Analysis of Single-Cell Transcriptomes Links Enrichment of Olfactory Receptors with Cancer Cell Differentiation Status and Prognosis
    ARTICLE https://doi.org/10.1038/s42003-020-01232-5 OPEN Analysis of single-cell transcriptomes links enrichment of olfactory receptors with cancer cell differentiation status and prognosis Siddhant Kalra1,7, Aayushi Mittal1,7, Krishan Gupta 1,2, Vrinda Singhal1, Anku Gupta2, Tripti Mishra3, ✉ ✉ 1234567890():,; Srivatsava Naidu4, Debarka Sengupta 1,2,5,6 & Gaurav Ahuja 1 Ectopically expressed olfactory receptors (ORs) have been linked with multiple clinically- relevant physiological processes. Previously used tissue-level expression estimation largely shadowed the potential role of ORs due to their overall low expression levels. Even after the introduction of the single-cell transcriptomics, a comprehensive delineation of expression dynamics of ORs in tumors remained unexplored. Our targeted investigation into single malignant cells revealed a complex landscape of combinatorial OR expression events. We observed differentiation-dependent decline in expressed OR counts per cell as well as their expression intensities in malignant cells. Further, we constructed expression signatures based on a large spectrum of ORs and tracked their enrichment in bulk expression profiles of tumor samples from The Cancer Genome Atlas (TCGA). TCGA tumor samples stratified based on OR-centric signatures exhibited divergent survival probabilities. In summary, our compre- hensive analysis positions ORs at the cross-road of tumor cell differentiation status and cancer prognosis. 1 Department of Computational Biology, Indraprastha Institute of Information Technology-Delhi (IIIT-Delhi), Okhla, Phase III, New Delhi 110020, India. 2 Department of Computer Science and Engineering, Indraprastha Institute of Information Technology-Delhi (IIIT-Delhi), Okhla, Phase III, New Delhi 110020, India. 3 Pathfinder Research and Training Foundation, 30/7 and 8, Knowledge Park III, Greater Noida, Uttar Pradesh 201308, India.
    [Show full text]
  • Primepcr™Assay Validation Report
    PrimePCR™Assay Validation Report Gene Information Gene Name olfactory receptor, family 4, subfamily C, member 11 Gene Symbol OR4C11 Organism Human Gene Summary Olfactory receptors interact with odorant molecules in the nose to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. Gene Aliases OR11-136, OR4C11P RefSeq Accession No. NC_000011.9, NT_167190.1 UniGene ID Hs.553620 Ensembl Gene ID ENSG00000172188 Entrez Gene ID 219429 Assay Information Unique Assay ID qHsaCED0018972 Assay Type SYBR® Green Detected Coding Transcript(s) ENST00000302231 Amplicon Context Sequence ACAGAAAGGCAATCTTAAGGCCAGGATAATCTGAGCTGTAGAGTGTATTAAAGAC CCTATCCAGGCAAGAACAATCAGGATGATGCAGACCTGCTGGCTCATGATGGTT GGG Amplicon Length (bp) 82 Chromosome Location 11:55371349-55371460 Assay Design Exonic Purification Desalted Validation Results Efficiency (%) 99 R2 0.9996 cDNA Cq Target not expressed in universal RNA Page 1/5 PrimePCR™Assay Validation Report cDNA Tm (Celsius) Target not expressed in universal RNA gDNA Cq Target not expressed
    [Show full text]